Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys
The spontaneous object recognition (SOR) task is one of the most widely used behavioral protocols to assess visual memory in animals. However, only recently was it shown that nonhuman primates also perform well on this task. Here we further characterized this new monkey recognition memory test by as...
Main Authors: | Oliveira, André Wagner Carvalho de, Pacheco, Jéssica V. N., Costa, Clara de Sena, Aquino, Jéssica, Maior, Rafael Plakoudi Souto, Barros, Marilia |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Elsevier Inc.
2021
|
Subjects: | |
Online Access: |
https://repositorio.unb.br/handle/10482/42452 https://doi.org/10.1016/j.pbb.2021.173300 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
ir-10482-42452 |
---|---|
recordtype |
dspace |
spelling |
ir-10482-424522021-11-25T12:27:54Z Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys Oliveira, André Wagner Carvalho de Pacheco, Jéssica V. N. Costa, Clara de Sena Aquino, Jéssica Maior, Rafael Plakoudi Souto Barros, Marilia Sagui Memória de reconhecimento Escopolamina MK-801 Donepezila The spontaneous object recognition (SOR) task is one of the most widely used behavioral protocols to assess visual memory in animals. However, only recently was it shown that nonhuman primates also perform well on this task. Here we further characterized this new monkey recognition memory test by assessing the performance of adult marmosets after an acute systemic administration of two putative amnesic agents: the competitive muscarinic acetylcholine receptor antagonist scopolamine (SCP; 0.05 mg/kg) and the noncompetitive N-methyl-d-aspartate glutamate receptor antagonist MK-801 (0.015 mg/kg). We also determined whether the acetylcholinesterase inhibitor donepezil (DNP; 0.50 mg/kg), a clinically-used cognitive enhancer, reverses memory deficits caused by either drug. The subjects had an initial 10 min sample trial where two identical neutral objects could be explored. After a 6 h retention interval, recognition was based on an exploratory preference for a new rather than familiar object during a 10 min test trial. Both SCP and MK-801 impaired the marmosets' performance on the SOR task, as both objects were explored equivalently. Co-administration of 0.50 mg/kg of DNP reversed the SCP- but not the MK-801-induced memory deficit. These results indicate that cholinergic and glutamatergic pathways mediate object recognition memory in the monkey SOR task. 2021-11-25T12:07:11Z 2021-11-25T12:07:11Z 2021-10-16 Artigo OLIVEIRA, André W. C. et al. Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys. Pharmacology Biochemistry and Behavior, v. 21, 173300, dez. 2021. DOI: https://doi.org/10.1016/j.pbb.2021.173300. https://repositorio.unb.br/handle/10482/42452 https://doi.org/10.1016/j.pbb.2021.173300 Inglês https://www.sciencedirect.com/science/article/abs/pii/S0091305721001994#! Acesso Restrito Elsevier Inc. |
institution |
REPOSITORIO UNB |
collection |
REPOSITORIO UNB |
language |
Inglês |
topic |
Sagui Memória de reconhecimento Escopolamina MK-801 Donepezila |
spellingShingle |
Sagui Memória de reconhecimento Escopolamina MK-801 Donepezila Oliveira, André Wagner Carvalho de Pacheco, Jéssica V. N. Costa, Clara de Sena Aquino, Jéssica Maior, Rafael Plakoudi Souto Barros, Marilia Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys |
description |
The spontaneous object recognition (SOR) task is one of the most widely used behavioral protocols to assess visual memory in animals. However, only recently was it shown that nonhuman primates also perform well on this task. Here we further characterized this new monkey recognition memory test by assessing the performance of adult marmosets after an acute systemic administration of two putative amnesic agents: the competitive muscarinic acetylcholine receptor antagonist scopolamine (SCP; 0.05 mg/kg) and the noncompetitive N-methyl-d-aspartate glutamate receptor antagonist MK-801 (0.015 mg/kg). We also determined whether the acetylcholinesterase inhibitor donepezil (DNP; 0.50 mg/kg), a clinically-used cognitive enhancer, reverses memory deficits caused by either drug. The subjects had an initial 10 min sample trial where two identical neutral objects could be explored. After a 6 h retention interval, recognition was based on an exploratory preference for a new rather than familiar object during a 10 min test trial. Both SCP and MK-801 impaired the marmosets' performance on the SOR task, as both objects were explored equivalently. Co-administration of 0.50 mg/kg of DNP reversed the SCP- but not the MK-801-induced memory deficit. These results indicate that cholinergic and glutamatergic pathways mediate object recognition memory in the monkey SOR task. |
format |
Artigo |
author |
Oliveira, André Wagner Carvalho de Pacheco, Jéssica V. N. Costa, Clara de Sena Aquino, Jéssica Maior, Rafael Plakoudi Souto Barros, Marilia |
author_sort |
Oliveira, André Wagner Carvalho de |
title |
Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys |
title_short |
Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys |
title_full |
Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys |
title_fullStr |
Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys |
title_full_unstemmed |
Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys |
title_sort |
scopolamine and mk-801 impair recognition memory in a new spontaneous object exploration task in monkeys |
publisher |
Elsevier Inc. |
publishDate |
2021 |
url |
https://repositorio.unb.br/handle/10482/42452 https://doi.org/10.1016/j.pbb.2021.173300 |
_version_ |
1721216632314920960 |
score |
13.657419 |